Author

F. Runa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Geller· 1 shared E. Vickers· 1 shared G. O. Soto· 1 shared I. Zervantonakis· 1 shared J. A. Kelber· 1 shared J. C. Tchou· 1 shared J. Cantor· 1 shared J. D. Humphries· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Geller

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Fibronectin, DHPS and SLC3A2 Signaling Cooperate to Control Tumor Spheroid Growth, Subcellular eIF5A1/2 Distribution and CDK4/6 Inhibitor Resistance

C. Geller, J. Maddela, R. Tuplano, F. Runa, Y. Adamian, R. Guth, G. O. Soto, L. Tomaneng, J. Cantor, J. A. Kelber

This study identifies a mechanism by which fibronectin modulates eIF5A1/2 localization and cell cycle progression in TNBC, revealing that targeting DHPS/SLC3A2 improves CDK4/6 inhibitor efficacy.

bioRxiv · Apr 13, 2023 · PreprintCancer Biology

A SNAI2-PEAK1 stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting a cytokine expression profile that converges on PI3K/Akt signaling

S. Hamalian, R. Güth, F. Runa, J. Molnar, E. Vickers, M. Agajanian, J. D. Humphries, M. J. Humphries, J. C. Tchou, I. Zervantonakis, J. Kelber

bioRxiv · May 15, 2020Cancer Biology